Tao Wang
Direttore/Membro del Consiglio presso GEMPHARMATECH CO., LTD.
Provenienza dei contatti di primo grado di Tao Wang
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 16 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Tao Wang tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Nanjing University | College/University | Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
MICRO-TECH (NANJING) CO.,LTD | Medical Specialties | Founder | |
Innolake Pharmaceuticals (Hangzhou) Co., Ltd.
Innolake Pharmaceuticals (Hangzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Innolake Pharmaceuticals (Hangzhou) Co., Ltd. is a company based in Hangzhou, China that engages in the development and commercialization of therapeutic drugs for tumors and immune system diseases. The Chinese company was founded in 2020 by Ru Lei Chen and Ming De Xia, with Ming De Xia serving as the CEO since 2020. | Pharmaceuticals: Major | Director/Board Member | |
University of Illinois | College/University | Graduate Degree | |
Nanjing University of Aeronautics & Astronautics | College/University | Masters Business Admin | |
Agricultural University of Hebei | College/University | Graduate Degree | |
China Pharmaceutical University | College/University | Graduate Degree | |
Nanjing Agricultural University | College/University | Doctorate Degree | |
NANJING SINOLIFE UNITED COMPANY LIMITED | Pharmaceuticals: Other | Director/Board Member | |
AVIT LTD. | Telecommunications Equipment | Director/Board Member | |
Suzhou Xiangyuan New Materials Co., Ltd.
Suzhou Xiangyuan New Materials Co., Ltd. Chemicals: SpecialtyProcess Industries Suzhou Xiangyuan New Materials Co., Ltd. principally engages in the research, development, production, and sale of polyurethane chain extenders. Its key products are fine chemical products and new polyurethane chain extenders. The company was founded by Jian Zhou on July 3, 2001 and is headquartered in Suzhou, China. | Chemicals: Specialty | Director/Board Member | |
Nanyang Technological University | College/University | Graduate Degree | |
JIANGSU HUALAN NEW PHARMACEUTICAL MATERIAL CO.,LTD. | Containers/Packaging | Director/Board Member | |
Genfleet Therapeutics (Shanghai), Inc.
Genfleet Therapeutics (Shanghai), Inc. Miscellaneous Commercial ServicesCommercial Services Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017. | Miscellaneous Commercial Services | Director/Board Member | |
Wuhan Polytechnic University | College/University | Undergraduate Degree | |
Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd.
Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd. Medical SpecialtiesHealth Technology Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd. is a private company that manufactures medical equipment. The company is based in Wuxi, China. The Chinese company was founded in 1999. The CEO is Qing Song Sheng. | Medical Specialties | Director/Board Member | |
Yale University | College/University | Doctorate Degree | |
Shanghai Jiao Tong University | College/University | Masters Business Admin | |
Thomas Jefferson University | College/University | Doctorate Degree | |
BANK OF NANJING CO., LTD. | Regional Banks | Director/Board Member | |
Auburn University | College/University | Doctorate Degree | |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
PHARMABLOCK SCIENCES (NANJING), INC. | Miscellaneous Commercial Services | Chief Executive Officer | |
NANJING MEDLANDER MEDICAL TECHNOLOGY CO.,LTD. | Medical Specialties | Director/Board Member | |
University of Mississippi | College/University | Masters Business Admin |
Statistiche
Distribuzione geografica
Cina | 20 |
Stati Uniti | 6 |
Singapore | 2 |
Settori
Consumer Services | 14 |
Health Technology | 7 |
Process Industries | 3 |
Commercial Services | 3 |
Electronic Technology | 2 |
Posizioni
Director/Board Member | 24 |
Independent Dir/Board Member | 10 |
Doctorate Degree | 7 |
Graduate Degree | 5 |
Masters Business Admin | 4 |
Contatti più connessi
Insiders | |
---|---|
Dan Liu | 6 |
Min Min Yang | 5 |
De Rong Leng | 4 |
Bo Yu | 4 |
Bin Qing Xiao | 3 |
Juan Du | 3 |
Xiang Gao | 2 |
Jing Zhao | 2 |
Zhong Yu Li | 2 |
Xing Bo Gu | 2 |
Cun Xiang Ju | 2 |
Tao Wen | 2 |
Hui Xin Yang | 2 |
Xiao Shan Jiao | 2 |
Yiou Wang | 2 |
- Borsa valori
- Insiders
- Tao Wang
- Connessioni Società